Eric M. Wallen, MD


Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA.  Who makes the decision regarding the treatment of clinically localized prostate cancer- the patient or physician?:  Results from a population-based study.  Cancer, 2012 Jul 11.  doi:  10.1002/cncr.27738.  Epub ahead of print.

Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME, Castle EP.  Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy:  With mean follow-up of 3.5 years.  Urol Oncol, 2012 Apr 23.  Epub ahead of print.

Ferguson JE 3rd, Goyal RK, Raynor MC, Nielsen ME, Pruthi RS, Brown PM, Wallen EM.  Cost analysis of robot-assisted laparoscopic versus hand-assisted laparoscopic partial nephrectomy.  J Endourol, 2012 Apr 26.  Epub ahead of print.

Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R, Wallen EM, Woods M, Pruthi RS.  Multi-institutional analysis of robotic radical cystectomy for bladder cancer:  perioperative outcomes and complications in 227 patients.  J Laparoendosc Adv Surg Tech A, 2012 Jan-Feb; 22(1):17-21.  Epub 2011 Dec 5.

Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK.  Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.  Eur Urol, 2012 Feb; 61(2):258-68.  Epub 2011 Oct 18.

Manvar AM, Rathmell WK, Ferguson J, Pruthi RS, Nielsen ME, Wallen EM, Nolan N, Raynor MC.  Carcinoma in a cadaveric transplant kidney.  Urology, 2012 Apr; 79(4):758-60.  Epub 2011 Oct 20.

Raynor MC, Lavien G, Nielsen M, Wallen EM, Pruthi RS.  Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion.  Urol Oncol, 2011 June 28.  Epub a head of print.

Whang YE, Armstrong AJ, Rathmell WK, Godley PA, Kim WY, Pruthi RS, Wallen EM, Crane JM, Moore DT, Grigson G, Morris K, Watkins CP, George DJ.  A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer.  Urol Oncol, 2011 Mar 9.  Epub ahead of print.

Coward RM, Smith A, Raynor M, Nielsen M, Wallen EM, Pruthi RS.  Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients.  Urology, 2011 May; 77(5):1111-4.  Epub 2011 Feb 18.

Manvar AM, Wallen EM, Pruthi RS, Nielsen ME.  Prognostic value of CA 125 in transitional cell carcinoma of the bladder.  Expert Rev Anticancer Ther, 2010 Dec; 10(12):1877-81.

Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, Rathmel WK.  Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct substypes and survival patterns.  Genes Cancer, 2010 Feb 1; 1(2):152-163.

Kimple RJ, Wallen EM, Pruthi R, Marks LB.  A simple algorithm to assess patient suitability for Calypso-seed implantation for four-dimensional prostate localization.  J Appl Clin Med Phys, 2009 Dec 3; 11(1):3107.

Cowey CL, Amin C, Pruthi RS, Wallen EM, Nielsen ME, Grigson G, Watkins C, Nance KV, Crane J, Jalkut M, Moore DT, Kim WY, Godley PA, Wahng YE, Fielding JR, Rathmell WK.  Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.  J clin Oncol, 2010 Mar 20; 28(9):1502-7.  Epub 2010 Feb 16.

Rathmell WK, Pruthi R, Wallen EM.  Neoadjuvant treatment of renal cell carcinoma.  Urol Oncol, 2010 Jan-Feb; 28(1):69-73.  Review.

Pruthi RS, Nielsen M, Smith A, Nix J, Schultz H, Wallen EM.  Fast track program in patients undergoing radical cystectomy:  results in 362 consecutive patients.  J Am Coll Surg, 2010 Jan; 210(1):93-9.  Epub 2009 Oct 28.

Pruthi RS, Nielsen M, Heathcote S, Wallen EM, Rathmell WK, Godley P, Whang Y, Fielding J, Schultz H, Grigson G, Smith A, Kim W.  A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy:  clinical and pathological outcomes.  BJU Int, 2010 Aug; 106(3):349-54.  Epub 2010 Jan 19.

Pruthi RS, Nix J, McRackan D, Hickerson A, Nielsen ME, Raynor M, Wallen EM.  Robotic-assisted laparoscopic intracorporeal urinary diversion.  Eur Urol, 2010 Jun; 27(6):1013-21.  Epub 2010 Jan 9.

Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA.  Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer:  a phase II trial.  Urol Oncol, 2011 Nov-Dec; 29(6):608-13.  Epub 2009 Dec 21.

Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM.  Robotic radical cystectomy for bladder cancer:  surgical and pathological outcomes in 100 consecutive cases.

Smith A, Kurpad R, Lal A, Nieslen M, Wallen EM, Pruthi RS.  Cost analysis of robotic versus open radical cystectomy for bladder cancer.  J urol, 2010 Feb; 183(2):505-9.  Epub 2009 Dec 14.

Pruthi RS, Wallen EM. Current status of robotic prostatectomy:  promises fulfilled.  J Urol, 2009; 181(6):2420-1.  Epub 2009 Apr 15.

Pruthi RS, Wallen EM. Robotic-assisted laparoscopic pelvic lymphadenectomy for bladder cancer:  a surgical atlas.  J Laparoendosc Adv Surg Tech A, 2009; 19(1):71-4.

Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM. Impact of marital status in patients undergoing radical cystectomy for bladder cancer.  World J Urol, epub 2009 Feb 15.

Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.  J Urol, 2009; 181(2):574-7; discussion 578.  epub 2008 Dec 13.

Pruthi RS, Stefaniak H, Hubbard JS, Wallen EM. Robot-assisted laparoscopic anterior pelvic exenteration for bladder cancer in the female patient.  J Laparoendosc Adv Surg Tech A, 2009; 19(1):23-7.


Search for additional publicatoins on PubMed using wallen em as search criteria.